The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer.

Yanan LuLing MaJianjun QinZhaoqi WangJia GuoYan ZhaoHongkai ZhangXu YanHui LiuHailiang LiIhab R KamelJin-Rong Qu

Published in: BMC cancer (2019)

In patients with esophageal cancer on neoadjuvant chemotherapy, several parameters can differentiate responders from non-responders, using both GRASP and VS-GR techniques. GRASP may be able to better differentiate these two groups compared to VS-GR. Trial registration for this prospective study: ChiCTR, ChiCTR-DOD-14005308. Registered 2 October 2014.

Keyphrases

neoadjuvant chemotherapy
locally advanced
contrast enhanced
lymph node
sentinel lymph node
magnetic resonance imaging
study protocol
clinical trial
phase iii
squamous cell carcinoma
phase ii
magnetic resonance
computed tomography